Boehringer Ingelheim

Main Sponsor

Web Boehringer Ingelheim website
Boehringer Ingelheim

When it comes to outsmarting cancer, we believe we’re brighter together. Guided by a commitment to evidence-based practice and integrity in research, we’re proud of our collaborative research approach that is dedicated to shedding light on the unsolved problems in oncology and improving lives for patients with cancer. 

Boehringer Ingelheim in Oncology

Through scientific innovation and collaboration, Boehringer Ingelheim is committed to discovering and developing novel cancer agents that improve the lives of patients with cancer. 

Let's Collaborate Logo Boeringher Ingelheim

To find out more about oncology meetings, congresses, symposia and other activities sponsored by
Boehringer Ingelheim, please follow the link to

Activities Sponsored by Boehringer Ingelheim

Boehringer Ingelheim has produced slide kits that discuss the epidemiology, disease classification and pathology of non-small-cell lung carcinoma (NSCLC), malignant pleural mesothelioma (MPM)head and neck squamous-cell carcinoma (HNSCC) and (squamous non-small-cell lung carcinoma) SqNSCLC.

Follow Boehringer Ingelheim on social media!

Follow us on Facebook

Follow us on Youtube

Follow us on Twitter

Memo inOncology SPECIAL ISSUE – Congress Report

Congress Report Special Issue Boeringher Ingelheim

Each memo inOncology SPECIAL ISSUE congress report delivers the latest in lung cancer research to come out of a major international oncology congress. Each issue is now translated into Chinese (Mandarin) and Japanese.

The content of these reports is produced by Springer, engaged by several societies and supported with an unrestricted educational grant by Boehringer Ingelheim.


WCLC 2017

ESMO 2017

ASCO 2017